Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Q4 Revenue Fell 12.7 Percent, Expects Q1 05 Receipts to Slide 32-40 Percent

NEW YORK, Feb. 17 (GenomeWeb News) - Ciphergen today reported a fall-off in total revenue in the fourth quarter, decreased R&D spending, and net income resulting from its sale late last year of its BioSepra business.


Total revenues for the three months ended Dec. 31., 2004, fell 12.7 percent to $10.1 million from $11.6 million year over year.


Ciphergen said R&D spending in the fourth quarter shrank 35.6 percent to $3.7 million from $5.8 million year over year.


The company said net income in the quarter swelled to $10.3 million, or $.35 per basic share, from a net loss of $6.7 million, or $.23 per basic share. The turnaround was the result of Ciphergen's sale late last year of its BioSepra unit for $35.8 million.


Ciphergen said it had around $35.4 million in cash and equivalents and $2.2 million in short-term investment as of Dec, 31, 2004.


Looking ahead, Ciphergen said it expects first-quarter revenue to fall between 32 and 40 percent to between $8 million and $9 million from $13.3 million in the first quarter of 2004.


However, the company expects 2005 revenue to increase by as much as 20 percent to between $44 million from $48 million from $40.2 million in 2004.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.